ABOUT EVENT
THE INDUSTRY-DEDICATED FORUM, FOCUSED ON EMERGING PEPTIDE-BASED THERAPEUTICS
The 2nd Peptide-Based Therapeutics Summit returns to unite a community dedicated to identifying, designing, synthesizing, and accelerating optimized peptide-based therapies from concept to clinic!
Returning for its second year, the summit will focus on the industry’s key areas of innovation, including elucidating and predicting peptide structure, applying AI/ML tools in combination with experimental approaches to design for function, and optimizing for passive cell permeability and oral bioavailability.
2
REFRESHED WORKSHOPS EXPLORING THE SYNERGY OF COMPUTATIONAL AND MEDICINAL CHEMISTRY TO DESIGN IMPACTFUL PEPTIDES BEYOND THE BRO5 SPACE
22+
WORLD-CLASS SPEAKERS, INCLUDING NIMBLE THERAPEUTICS, PEPTIDREAM, CHUGAI
&MORE
80+
PEPTIDE COMPUTATIONAL EXPERTS, MEDICINAL CHEMISTS AND FORMULATION SPECIALISTS
We are excited to present our work to the community and join our colleagues from industry to discuss the future of Peptide Therapeutics and build strategies to continue the momentum of bringing peptide-based therapeutics to patients – Christian Cunningham, Chief Scientific Officer, PeptiDream
EXPECT TO ENGAGE IN INTERACTIVE DISCUSSIONS ON:
Exploring the diversity of AI/ML-driven platform technologies and computational approaches underpinning peptide 3D structure prediction, hit generation and lead optimization of functional groups, bonds and angles
Harnessing medicinal chemistry to design peptides with cellular penetrative functionality by tweaking charge residues for hydrophobicity and avoiding the risk of toxicity
Leveraging mRNA display and DNA-encoded libraries to accelerate peptide-based therapeutic discovery and screening
Formulating peptide therapies with a sweet spot between target binding affinity, solubility and stability, as well as desired safety and toxicity profiles
Realizing the game-changing potential of creating orally bioavailable peptide therapies
Examining the opportunity of peptides as drug delivery vehicles in the format of peptide-drug conjugates and other applications
Comprehending the therapeutic and commercial opportunity of taking market share away from small molecules and biologics across targets that have been “undruggable” to date
